Ftse Mib
33.305,46
-1,34%
DAX
19.060,31
-0,60%
S&P 500
5.916,98
0,40%
NASDAQ
18.987,47
1,04%
Bitcoin
91.810,93
1,41%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Magenta Therapeutics Inc (MGTA) Magenta Therapeutics Inc (MGTA) Notizie

Magenta Therapeutics Inc

MGTA
11,1936
0,00 (0,00%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/9/202422:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/9/202422:06EDGAR2Form 8-K - Current report
13/9/202402:45EDGAR2Form SC 13D/A - General Statement of Acquisition of..
08/8/202422:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/8/202422:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/8/202422:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:06EDGAR2Form 8-K - Current report
06/6/202414:00EDGAR2Form 8-K - Current report
29/5/202402:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202401:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202423:24EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/5/202423:20EDGAR2Form 8-K - Current report
09/5/202422:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:08EDGAR2Form 8-K - Current report
11/4/202422:10EDGAR2Form ARS - Annual Report to Security Holders
11/4/202422:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/4/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
02/4/202400:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02/4/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/3/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/3/202422:02EDGAR2Form S-1/A - General form for registration of securities..
21/3/202421:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21/3/202421:04EDGAR2Form 8-K - Current report
14/2/202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:52EDGAR2Form S-1/A - General form for registration of securities..
02/2/202422:32EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202418:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
26/1/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202423:26EDGAR2Form SC 13D/A - General statement of acquisition of..
22/1/202413:34EDGAR2Form 8-K - Current report
08/1/202414:02EDGAR2Form 8-K - Current report
21/12/202323:08EDGAR2Form S-1/A - General form for registration of securities..
21/12/202322:16EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 11,1936

La tua Cronologia

NASDAQ
MGTA
Magenta Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network